Blog
Revolutionary Alliance Launches AI-Driven Eye Therapy
👀 Three companies join forces to develop gene therapy for eye diseases, using AI and machine learning algorithms. 🧬👁️🔬
Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70
🤖 Vendor-agnostic automation system for cell and gene therapy manufacturing reduces errors and lowers costs.💡
Scientists Discover Fat-Burning Breakthrough to Fight Obesity
📢 Researchers switch on brown fat cells, revolutionizing obesity research 🔥. Blocking enzyme AC3-AT helps combat obesity in mice. 💡👩🔬 Further research needed.
Revolutionary Cell Line Service Enhances Lentivirus Production
🔍 Asimov expands lentivirus production with cell line development service, reducing costs and supply chain disruptions. 🧬💰🚀
NIIMBL Boosts Biopharmaceutical Innovation with Funding
🔍 NIIMBL backs bioprocess tech and training innovation in funding round to accelerate biopharmaceutical innovation and boost workforce skills.
Breakthrough Cancer Treatment Targets Solid Tumors
📰 FDA approved first cancer therapy targeting solid tumors using tumor-infiltrating lymphocytes (TILs). Exciting potential for cancer treatment! 👩⚕️🦠🔍
Revolutionary Standardized Viral Vector Manufacturing for Gene Therapy
📰 AGC Biologics offers standardized viral vector manufacturing, covering the entire process from transfection to purification. 🔬💡🌐
Revolutionary Ribosome Engineering: Lowering Drug Costs and Fueling the Bioeconomy
💡 Ribosome pool engineering 💊🌱🧬 can transform the bioeconomy by increasing protein synthesis yields and lowering drug manufacturing costs. 🔬🚀
Revolutionary Cell Manufacturing Lines for Gene Therapies: Cytiva’s Game-Changing Solution
📢 Cytiva introduces new cell manufacturing lines for viral vectors in gene therapies, aiming to standardize manufacturing and reduce costs. 💼💡🔬🚀
Revolutionizing Cell Therapy Manufacturing: Faster & Safer
🔎 This article explores the challenges in cell therapy manufacturing and the urgency for faster processes. It discusses closed-process systems, bioreactors, and rapid testing methods to improve efficiency. It emphasizes the significance of streamlined manufacturing and quality control testing for faster treatment delivery. The need for a common manufacturing platform and scalability in cell therapy production is also addressed.
